We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

AstraZeneca mulls delisting its Indian arm

News

Executive Summary

AstraZeneca may take another shot at delisting its Indian arm by buying the residual 10% in its Indian arm, AstraZeneca Pharma India, against a backdrop of amendments to listing rules in India that mandate a minimum threshold level of public holding of 25% for all listed companies by 2013, as against 10% earlier.